Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

[Gene therapy: where do we stand?].

Cavazzana-Calvo M.

Rev Prat. 2013 Apr;63(4):457-61. French.

PMID:
23682464
2.

Gene therapy of primary T cell immunodeficiencies.

Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M.

Gene. 2013 Aug 10;525(2):170-3. doi: 10.1016/j.gene.2013.03.092. Epub 2013 Apr 10. Review.

3.

Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning.

Boelens JJ, Aldenhoven M, Purtill D, Ruggeri A, Defor T, Wynn R, Wraith E, Cavazzana-Calvo M, Rovelli A, Fischer A, Tolar J, Prasad VK, Escolar M, Gluckman E, O'Meara A, Orchard PJ, Veys P, Eapen M, Kurtzberg J, Rocha V; Eurocord; Inborn Errors Working Party of European Blood and Marrow Transplant group; Duke University Blood and Marrow Transplantation Program; Centre for International Blood and Marrow Research.

Blood. 2013 May 9;121(19):3981-7. doi: 10.1182/blood-2012-09-455238. Epub 2013 Mar 14.

4.

Characteristics and outcome of early-onset, severe forms of Wiskott-Aldrich syndrome.

Mahlaoui N, Pellier I, Mignot C, Jais JP, Bilhou-Nabéra C, Moshous D, Neven B, Picard C, de Saint-Basile G, Cavazzana-Calvo M, Blanche S, Fischer A.

Blood. 2013 Feb 28;121(9):1510-6. doi: 10.1182/blood-2012-08-448118. Epub 2012 Dec 20.

5.

Haematopoietic stem cell transplantation for SCID patients: where do we stand?

Cavazzana-Calvo M, André-Schmutz I, Fischer A.

Br J Haematol. 2013 Jan;160(2):146-52. doi: 10.1111/bjh.12119. Epub 2012 Nov 20. Review.

PMID:
23167301
6.

Primary microcephaly, impaired DNA replication, and genomic instability caused by compound heterozygous ATR mutations.

Mokrani-Benhelli H, Gaillard L, Biasutto P, Le Guen T, Touzot F, Vasquez N, Komatsu J, Conseiller E, Pïcard C, Gluckman E, Francannet C, Fischer A, Durandy A, Soulier J, de Villartay JP, Cavazzana-Calvo M, Revy P.

Hum Mutat. 2013 Feb;34(2):374-84. doi: 10.1002/humu.22245. Epub 2012 Dec 20.

PMID:
23111928
7.

Gene therapy for primary immunodeficiencies: Part 1.

Cavazzana-Calvo M, Fischer A, Hacein-Bey-Abina S, Aiuti A.

Curr Opin Immunol. 2012 Oct;24(5):580-4. doi: 10.1016/j.coi.2012.08.008. Epub 2012 Sep 12. Review.

PMID:
22981681
8.

Massive expansion of maternal T cells in response to EBV infection in a patient with SCID-Xl.

Touzot F, Dal-Cortivo L, Verkarre V, Lim A, Crucis-Armengaud A, Moshous D, Héritier S, Frange P, Kaltenbach S, Blanche S, Picard C, Hacein-Bey-Abina S, Cavazzana-Calvo M, Fischer A.

Blood. 2012 Aug 30;120(9):1957-9. doi: 10.1182/blood-2012-04-426833. No abstract available.

9.

Gene therapy for primary immunodeficiencies: Part 2.

Aiuti A, Bacchetta R, Seger R, Villa A, Cavazzana-Calvo M.

Curr Opin Immunol. 2012 Oct;24(5):585-91. doi: 10.1016/j.coi.2012.07.012. Epub 2012 Aug 18. Review.

PMID:
22909900
10.

Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency.

Hassan A, Booth C, Brightwell A, Allwood Z, Veys P, Rao K, Hönig M, Friedrich W, Gennery A, Slatter M, Bredius R, Finocchi A, Cancrini C, Aiuti A, Porta F, Lanfranchi A, Ridella M, Steward C, Filipovich A, Marsh R, Bordon V, Al-Muhsen S, Al-Mousa H, Alsum Z, Al-Dhekri H, Al Ghonaium A, Speckmann C, Fischer A, Mahlaoui N, Nichols KE, Grunebaum E, Al Zahrani D, Roifman CM, Boelens J, Davies EG, Cavazzana-Calvo M, Notarangelo L, Gaspar HB; Inborn Errors Working Party of the European Group for Blood and Marrow Transplantation and European Society for Immunodeficiency.

Blood. 2012 Oct 25;120(17):3615-24; quiz 3626. doi: 10.1182/blood-2011-12-396879. Epub 2012 Jul 12.

11.

Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival.

Rubio MT, Moreira-Teixeira L, Bachy E, Bouillié M, Milpied P, Coman T, Suarez F, Marcais A, Sibon D, Buzyn A, Caillat-Zucman S, Cavazzana-Calvo M, Varet B, Dy M, Hermine O, Leite-de-Moraes M.

Blood. 2012 Sep 6;120(10):2144-54. doi: 10.1182/blood-2012-01-404673. Epub 2012 Jun 22.

12.

A specific time course for mobilization of peripheral blood CD34+ cells after plerixafor injection in very poor mobilizer patients: impact on the timing of the apheresis procedure.

Lefrère F, Mauge L, Réa D, Ribeil JA, Dal Cortivo L, Brignier AC, Aoun C, Larghéro J, Cavazzana-Calvo M, Micléa JM.

Transfusion. 2013 Mar;53(3):564-9. doi: 10.1111/j.1537-2995.2012.03744.x. Epub 2012 Jun 21.

PMID:
22725259
13.

Human T-lymphoid progenitors generated in a feeder-cell-free Delta-like-4 culture system promote T-cell reconstitution in NOD/SCID/γc(-/-) mice.

Reimann C, Six E, Dal-Cortivo L, Schiavo A, Appourchaux K, Lagresle-Peyrou C, de Chappedelaine C, Ternaux B, Coulombel L, Beldjord K, Cavazzana-Calvo M, Andre-Schmutz I.

Stem Cells. 2012 Aug;30(8):1771-80. doi: 10.1002/stem.1145.

14.

Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells.

Ceccaldi R, Parmar K, Mouly E, Delord M, Kim JM, Regairaz M, Pla M, Vasquez N, Zhang QS, Pondarre C, Peffault de Latour R, Gluckman E, Cavazzana-Calvo M, Leblanc T, Larghero J, Grompe M, Socié G, D'Andrea AD, Soulier J.

Cell Stem Cell. 2012 Jul 6;11(1):36-49. doi: 10.1016/j.stem.2012.05.013. Epub 2012 Jun 7.

15.

Amniotic fluid stem cells restore the muscle cell niche in a HSA-Cre, Smn(F7/F7) mouse model.

Piccoli M, Franzin C, Bertin E, Urbani L, Blaauw B, Repele A, Taschin E, Cenedese A, Zanon GF, André-Schmutz I, Rosato A, Melki J, Cavazzana-Calvo M, Pozzobon M, De Coppi P.

Stem Cells. 2012 Aug;30(8):1675-84. doi: 10.1002/stem.1134.

16.

Critical variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency.

van der Loo JC, Swaney WP, Grassman E, Terwilliger A, Higashimoto T, Schambach A, Hacein-Bey-Abina S, Nordling DL, Cavazzana-Calvo M, Thrasher AJ, Williams DA, Reeves L, Malik P.

Gene Ther. 2012 Aug;19(8):872-6. doi: 10.1038/gt.2012.37. Epub 2012 May 3.

17.

Lentiviral hematopoietic cell gene therapy for X-linked adrenoleukodystrophy.

Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Bougnères P, Schmidt M, Kalle CV, Fischer A, Cavazzana-Calvo M, Aubourg P.

Methods Enzymol. 2012;507:187-98. doi: 10.1016/B978-0-12-386509-0.00010-7.

PMID:
22365775
18.

Strategies for retrovirus-based correction of severe, combined immunodeficiency (SCID).

Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M.

Methods Enzymol. 2012;507:15-27. doi: 10.1016/B978-0-12-386509-0.00002-8.

PMID:
22365767
19.

Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?

Fernandes JF, Rocha V, Labopin M, Neven B, Moshous D, Gennery AR, Friedrich W, Porta F, Diaz de Heredia C, Wall D, Bertrand Y, Veys P, Slatter M, Schulz A, Chan KW, Grimley M, Ayas M, Gungor T, Ebell W, Bonfim C, Kalwak K, Taupin P, Blanche S, Gaspar HB, Landais P, Fischer A, Gluckman E, Cavazzana-Calvo M; Eurocord and Inborn Errors Working Party of European Group for Blood and Marrow Transplantation.

Blood. 2012 Mar 22;119(12):2949-55. doi: 10.1182/blood-2011-06-363572. Epub 2012 Feb 3.

20.

Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapy.

Deichmann A, Brugman MH, Bartholomae CC, Schwarzwaelder K, Verstegen MM, Howe SJ, Arens A, Ott MG, Hoelzer D, Seger R, Grez M, Hacein-Bey-Abina S, Cavazzana-Calvo M, Fischer A, Paruzynski A, Gabriel R, Glimm H, Abel U, Cattoglio C, Mavilio F, Cassani B, Aiuti A, Dunbar CE, Baum C, Gaspar HB, Thrasher AJ, von Kalle C, Schmidt M, Wagemaker G.

Mol Ther. 2011 Nov;19(11):2031-9. doi: 10.1038/mt.2011.178. Epub 2011 Aug 23.

21.

Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study.

Moratto D, Giliani S, Bonfim C, Mazzolari E, Fischer A, Ochs HD, Cant AJ, Thrasher AJ, Cowan MJ, Albert MH, Small T, Pai SY, Haddad E, Lisa A, Hambleton S, Slatter M, Cavazzana-Calvo M, Mahlaoui N, Picard C, Torgerson TR, Burroughs L, Koliski A, Neto JZ, Porta F, Qasim W, Veys P, Kavanau K, Hönig M, Schulz A, Friedrich W, Notarangelo LD.

Blood. 2011 Aug 11;118(6):1675-84. doi: 10.1182/blood-2010-11-319376. Epub 2011 Jun 9.

22.

Gene therapy for primary adaptive immune deficiencies.

Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M.

J Allergy Clin Immunol. 2011 Jun;127(6):1356-9. doi: 10.1016/j.jaci.2011.04.030. Review.

PMID:
21624615
23.

Loss of p19Arf in a Rag1(-/-) B-cell precursor population initiates acute B-lymphoblastic leukemia.

Hauer J, Mullighan C, Morillon E, Wang G, Bruneau J, Brousse N, Lelorc'h M, Romana S, Boudil A, Tiedau D, Kracker S, Bushmann FD, Borkhardt A, Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M.

Blood. 2011 Jul 21;118(3):544-53. doi: 10.1182/blood-2010-09-305383. Epub 2011 May 26.

24.

Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer.

Pike-Overzet K, Rodijk M, Ng YY, Baert MR, Lagresle-Peyrou C, Schambach A, Zhang F, Hoeben RC, Hacein-Bey-Abina S, Lankester AC, Bredius RG, Driessen GJ, Thrasher AJ, Baum C, Cavazzana-Calvo M, van Dongen JJ, Staal FJ.

Leukemia. 2011 Sep;25(9):1471-83. doi: 10.1038/leu.2011.106. Epub 2011 May 27.

PMID:
21617701
25.

Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meeting.

Tolar J, Adair JE, Antoniou M, Bartholomae CC, Becker PS, Blazar BR, Bueren J, Carroll T, Cavazzana-Calvo M, Clapp DW, Dalgleish R, Galy A, Gaspar HB, Hanenberg H, Von Kalle C, Kiem HP, Lindeman D, Naldini L, Navarro S, Renella R, Rio P, Sevilla J, Schmidt M, Verhoeyen E, Wagner JE, Williams DA, Thrasher AJ.

Mol Ther. 2011 Jul;19(7):1193-8. doi: 10.1038/mt.2011.78. Epub 2011 May 3. Review.

26.

Cytokines and culture medium have a major impact on human in vitro T-cell differentiation.

Six EM, Benjelloun F, Garrigue A, Bonhomme D, Morillon E, Rouiller J, Cacavelli L, Blondeau J, Beldjord K, Hacein-Bey-Abina S, Cavazzana-Calvo M, André-Schmutz I.

Blood Cells Mol Dis. 2011 Jun 15;47(1):72-8. doi: 10.1016/j.bcmd.2011.04.001. Epub 2011 Apr 29.

PMID:
21531153
27.

Occurrence of myelodysplastic syndrome in 2 patients with reticular dysgenesis.

Lagresle-Peyrou C, Neven B, Six E, Picard C, Demerens-de Chappedelaine C, Bertrand Y, Jabado N, Chomienne C, Radford-Weiss I, Brouzes C, Asnafi V, MacIntyre E, Donadieu J, Beaupain B, Fenaux P, Eclache V, Fischer A, Cavazzana-Calvo M.

J Allergy Clin Immunol. 2011 Jul;128(1):230-232.e2. doi: 10.1016/j.jaci.2011.02.008. Epub 2011 Mar 31. No abstract available.

PMID:
21458044
28.

A method to sequence and quantify DNA integration for monitoring outcome in gene therapy.

Brady T, Roth SL, Malani N, Wang GP, Berry CC, Leboulch P, Hacein-Bey-Abina S, Cavazzana-Calvo M, Papapetrou EP, Sadelain M, Savilahti H, Bushman FD.

Nucleic Acids Res. 2011 Jun;39(11):e72. doi: 10.1093/nar/gkr140. Epub 2011 Mar 16.

29.

First experience of autologous peripheral blood stem cell mobilization with biosimilar granulocyte colony-stimulating factor.

Lefrère F, Brignier AC, Elie C, Ribeil JA, Bernimoulin M, Aoun C, Dal Cortivo L, Delarue R, Hermine O, Cavazzana-Calvo M.

Adv Ther. 2011 Apr;28(4):304-10. doi: 10.1007/s12325-011-0009-1. Epub 2011 Mar 10.

PMID:
21400232
30.

Is normal hematopoiesis maintained solely by long-term multipotent stem cells?

Cavazzana-Calvo M, Fischer A, Bushman FD, Payen E, Hacein-Bey-Abina S, Leboulch P.

Blood. 2011 Apr 28;117(17):4420-4. doi: 10.1182/blood-2010-09-255679. Epub 2011 Feb 8. Review.

31.

Gene therapy for primary immunodeficiencies.

Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M.

Hematol Oncol Clin North Am. 2011 Feb;25(1):89-100. doi: 10.1016/j.hoc.2010.11.007.

PMID:
21236392
32.

[Gene therapy of x-linked adrenoleukodystrophy using hematopoietic stem cells and a lentiviral vector].

Cartier N, Hacein-Bey-Abina S, Von Kalle C, Bougnères P, Fischer A, Cavazzana-Calvo M, Aubourg P.

Bull Acad Natl Med. 2010 Feb;194(2):255-64; discussion 264-8. French.

PMID:
21166117
33.

X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.

Booth C, Gilmour KC, Veys P, Gennery AR, Slatter MA, Chapel H, Heath PT, Steward CG, Smith O, O'Meara A, Kerrigan H, Mahlaoui N, Cavazzana-Calvo M, Fischer A, Moshous D, Blanche S, Pachlopnik Schmid J, Latour S, de Saint-Basile G, Albert M, Notheis G, Rieber N, Strahm B, Ritterbusch H, Lankester A, Hartwig NG, Meyts I, Plebani A, Soresina A, Finocchi A, Pignata C, Cirillo E, Bonanomi S, Peters C, Kalwak K, Pasic S, Sedlacek P, Jazbec J, Kanegane H, Nichols KE, Hanson IC, Kapoor N, Haddad E, Cowan M, Choo S, Smart J, Arkwright PD, Gaspar HB.

Blood. 2011 Jan 6;117(1):53-62. doi: 10.1182/blood-2010-06-284935. Epub 2010 Oct 6. Erratum in: Blood. 2011 Nov 3;118(18):5060. Pachlopnick-Schmid, Jana [corrected to Pachlopnik Schmid, Jana].

34.

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia.

Cavazzana-Calvo M, Payen E, Negre O, Wang G, Hehir K, Fusil F, Down J, Denaro M, Brady T, Westerman K, Cavallesco R, Gillet-Legrand B, Caccavelli L, Sgarra R, Maouche-Chrétien L, Bernaudin F, Girot R, Dorazio R, Mulder GJ, Polack A, Bank A, Soulier J, Larghero J, Kabbara N, Dalle B, Gourmel B, Socie G, Chrétien S, Cartier N, Aubourg P, Fischer A, Cornetta K, Galacteros F, Beuzard Y, Gluckman E, Bushman F, Hacein-Bey-Abina S, Leboulch P.

Nature. 2010 Sep 16;467(7313):318-22. doi: 10.1038/nature09328.

35.

Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?

Gennery AR, Slatter MA, Grandin L, Taupin P, Cant AJ, Veys P, Amrolia PJ, Gaspar HB, Davies EG, Friedrich W, Hoenig M, Notarangelo LD, Mazzolari E, Porta F, Bredius RG, Lankester AC, Wulffraat NM, Seger R, Güngör T, Fasth A, Sedlacek P, Neven B, Blanche S, Fischer A, Cavazzana-Calvo M, Landais P; Inborn Errors Working Party of the European Group for Blood and Marrow Transplantation; European Society for Immunodeficiency.

J Allergy Clin Immunol. 2010 Sep;126(3):602-10.e1-11. doi: 10.1016/j.jaci.2010.06.015. Epub 2010 Jul 31.

PMID:
20673987
36.

Efficacy of gene therapy for X-linked severe combined immunodeficiency.

Hacein-Bey-Abina S, Hauer J, Lim A, Picard C, Wang GP, Berry CC, Martinache C, Rieux-Laucat F, Latour S, Belohradsky BH, Leiva L, Sorensen R, Debré M, Casanova JL, Blanche S, Durandy A, Bushman FD, Fischer A, Cavazzana-Calvo M.

N Engl J Med. 2010 Jul 22;363(4):355-64. doi: 10.1056/NEJMoa1000164.

37.

Advances in adoptive immunotherapy to accelerate T-cellular immune reconstitution after HLA-incompatible hematopoietic stem cell transplantation.

Reimann C, Dal Cortivo L, Hacein-Bey-Abina S, Fischer A, André-Schmutz I, Cavazzana-Calvo M.

Immunotherapy. 2010 Jul;2(4):481-96. doi: 10.2217/imt.10.36. Review.

PMID:
20636003
38.

Gene therapy for primary immunodeficiencies.

Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M.

Immunol Allergy Clin North Am. 2010 May;30(2):237-48. doi: 10.1016/j.iac.2010.02.002. Review. Erratum in: Immunol Allergy Clin North Am. 2011 May;31(2): I. Cavazanna-Calvo, M [corrected to Cavazzana-Calvo, M].

PMID:
20493399
39.

20 years of gene therapy for SCID.

Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M.

Nat Immunol. 2010 Jun;11(6):457-60. doi: 10.1038/ni0610-457. No abstract available.

PMID:
20485269
40.

A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells.

Zhou S, Mody D, DeRavin SS, Hauer J, Lu T, Ma Z, Hacein-Bey Abina S, Gray JT, Greene MR, Cavazzana-Calvo M, Malech HL, Sorrentino BP.

Blood. 2010 Aug 12;116(6):900-8. doi: 10.1182/blood-2009-10-250209. Epub 2010 May 10.

41.

Clinical and immunologic outcome of patients with cartilage hair hypoplasia after hematopoietic stem cell transplantation.

Bordon V, Gennery AR, Slatter MA, Vandecruys E, Laureys G, Veys P, Qasim W, Friedrich W, Wulfraat NM, Scherer F, Cant AJ, Fischer A, Cavazzana-Calvo M, Bredius RG, Notarangelo LD, Mazzolari E, Neven B, Güngör T; Inborn Error Working Party of the European Bone Marrow Transplantation (EBMT) group.

Blood. 2010 Jul 8;116(1):27-35. doi: 10.1182/blood-2010-01-259168. Epub 2010 Apr 7. Erratum in: Blood. 2010 Sep 30;116(13):2402. Waseem, Qasim [corrected to Qasim, Waseem];Tayfun, Güngör [corrected to Güngör, Tayfun]. Blood. 2011 Feb 10;117(6):2077. Cavazanna-Calvo, Marina [corrected to Cavazzana-Calvo, Marina].

42.

Lymphomagenesis in SCID-X1 mice following lentivirus-mediated phenotype correction independent of insertional mutagenesis and gammac overexpression.

Ginn SL, Liao SH, Dane AP, Hu M, Hyman J, Finnie JW, Zheng M, Cavazzana-Calvo M, Alexander SI, Thrasher AJ, Alexander IE.

Mol Ther. 2010 May;18(5):965-76. doi: 10.1038/mt.2010.50. Epub 2010 Mar 30.

43.

Bone marrow transplantation for primary immunodeficiency diseases.

Szabolcs P, Cavazzana-Calvo M, Fischer A, Veys P.

Pediatr Clin North Am. 2010 Feb;57(1):207-37. doi: 10.1016/j.pcl.2009.12.004. Review.

PMID:
20307719
44.

Dynamics of gene-modified progenitor cells analyzed by tracking retroviral integration sites in a human SCID-X1 gene therapy trial.

Wang GP, Berry CC, Malani N, Leboulch P, Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M, Bushman FD.

Blood. 2010 Jun 3;115(22):4356-66. doi: 10.1182/blood-2009-12-257352. Epub 2010 Mar 12.

45.

[Ten years of gene therapy: thoughts and perspectives].

Cavazzana-Calvo M, Hacein-Bey-Abina S, Fischer A.

Med Sci (Paris). 2010 Feb;26(2):115-8. doi: 10.1051/medsci/2010262115. French. No abstract available.

46.

The biology of allogeneic hematopoietic cell resistance.

Shizuru JA, Bhattacharya D, Cavazzana-Calvo M.

Biol Blood Marrow Transplant. 2010 Jan;16(1 Suppl):S2-7. doi: 10.1016/j.bbmt.2009.11.005. Epub 2009 Nov 12. Review.

47.

Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy.

Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G, Schmidt M, Kutschera I, Vidaud M, Abel U, Dal-Cortivo L, Caccavelli L, Mahlaoui N, Kiermer V, Mittelstaedt D, Bellesme C, Lahlou N, Lefrère F, Blanche S, Audit M, Payen E, Leboulch P, l'Homme B, Bougnères P, Von Kalle C, Fischer A, Cavazzana-Calvo M, Aubourg P.

Science. 2009 Nov 6;326(5954):818-23. doi: 10.1126/science.1171242.

48.

Immune reconstitution after haematopoietic stem cell transplantation: obstacles and anticipated progress.

Cavazzana-Calvo M, André-Schmutz I, Dal Cortivo L, Neven B, Hacein-Bey-Abina S, Fischer A.

Curr Opin Immunol. 2009 Oct;21(5):544-8. doi: 10.1016/j.coi.2009.08.001. Epub 2009 Sep 18. Review.

PMID:
19766472
49.

Hematopoietic stem cell transplantation in Griscelli syndrome type 2: a single-center report on 10 patients.

Pachlopnik Schmid J, Moshous D, Boddaert N, Neven B, Dal Cortivo L, Tardieu M, Cavazzana-Calvo M, Blanche S, de Saint Basile G, Fischer A.

Blood. 2009 Jul 2;114(1):211-8. doi: 10.1182/blood-2009-02-207845. Epub 2009 Apr 29.

50.

Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome.

Boelens JJ, Rocha V, Aldenhoven M, Wynn R, O'Meara A, Michel G, Ionescu I, Parikh S, Prasad VK, Szabolcs P, Escolar M, Gluckman E, Cavazzana-Calvo M, Kurtzberg J; EUROCORD, Inborn error Working Party of EBMT and Duke University.

Biol Blood Marrow Transplant. 2009 May;15(5):618-25. doi: 10.1016/j.bbmt.2009.01.020.

Supplemental Content

Loading ...
Support Center